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Summary: Some patients undergoing epilepsy surgery suffer from early postoperative
seizures which may have a negative impact on later outcome. Factors contributing to
these seizures have not to date been examined systematically. We hypothesized that
reduction of postoperative serum levels of antiepileptic drugs (AED) may be one risk
factor for early postoperative seizures.
Methods: We retrospectively reviewedmedical records from 20 patients treated with
lamotrigine (LTG) who underwent epilepsy surgery between January 1997 and Feb-
ruary 2004. Demographic data, anaesthesiological and surgical procedures, co-med-
ication, and pre- as well as one or more postoperative LTG serum levels were
evaluated.
Results: We found a significant decrease in LTG serum levels, amounting to more than
20% (mean 46%, range 21.9—69.1%), in 16 of 20 patients (80%). Six patients (30%)
suffered from seizures in the first 2 weeks after surgery. In three patients, post-
operative seizures occurred isochronically with the LTG serum level nadir. The
magnitude of the reduction in serum levels was not influenced by age, sex, duration
of the operation, the type of anaesthetic drugs or the postoperative co-medication.
Discussion: Reductions in LTG serum levels are a relevant contributing factor for early
postoperative seizures. Postoperative alteration of the gastrointestinal motility and* Corresponding author at: Cecilie-Vogt-Clinic for Molecular Neurology, Charite´platz 1, D-10098 Berlin, Germany.
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transient time leading to delayed absorption and reduced bioavailability of AEDmay be
a major risk factor. Therefore, close monitoring of postoperative LTG serum levels is
necessary and should lead to a temporary dose augmentation and/or anticonvulsant co-
medication with benzodiazepines in case of a pronounced reduction of serum levels.
# 2007 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.Introduction
Epilepsy surgery is an established therapeutic alter-
native for a subgroup of patients with medically
intractable focal epilepsies.1 Although as many as
49% of patients may develop seizures in the early
postoperative period and these seizures may pre-
dict subsequent seizure recurrence,2—4 our knowl-
edge of the precipitating conditions of seizures in
the first few postoperative days is sparse. One of
these conditions might be fluctuations in the serum
levels of the antiepileptic drugs (AED) usually con-
tinued after surgery for a duration of at least 2
years. Few retrospective studies have previously
assessed changes in postoperative serum levels of
carbamazepine (CBZ), lamotrigine (LTG) or oxcar-
bazepine (OXC).5—8 Our observation of early post-
operative seizures associated with a pronounced
decrease in LTG serum levels a few days after
surgery in two of our patients prompted us to per-
form a systematic retrospective review of medical
records as well as surgery and anaesthesia protocols
from patients operated on in our clinic under med-
ication with LTG.Figure 1 Pre- and postoperative LTG serum levels. X-
axis–—LTG serum levels at different timepoints: preopera-
tive serum level, postoperative serum levels at POD 1/2,
3/4, 5/6, 7/8, 9/10 and 11—13. Y-axis–—LTG serum level in
mg/l. Red circles indicate patients with seizures isochro-
nic to postoperative serum level nadir. (For interpretation
of the references to colour in this figure legend, the
reader is referred to the web version of the article.)Patients and methods
Patients and procedures
Out of a total number of 272 surgically treated
epilepsy patients (anterior temporal lobectomy/
amygdalohippocampectomy, implantation of sub-
dural grid electrodes) between January 1997 and
February 2004, we identified 20 patients (12 female,
8 male,mean age 34 years (range 13—56)), whowere
on stable medication with LTG at least 1 month prior
to surgery and from whom at least one serum level
from the last or second last day before surgery and
from 1 postoperative day (POD) during the first 2
weeks after surgery was available. The number of
available postoperative LTG serum levels and the
duration of the follow-up period ranged from 1 to 6
and from POD 1/2 to POD 13, respectively (Fig. 1). All
serum samples were drawn during drug fasting in the
morning. Mean preoperative LTG dose was 551 mg/
day (200—800, S.D. 136.7). Twelve patients had an
LTGmonotherapy, 8 patients received co-medication
with other AED (2 CBZ (1000 mg, 1800 mg), 3 levetir-acetam (LEV) (2000 mg, 3000 mg, 3500 mg), 1 val-
proic acid (VPA) (2000 mg), 1 OXC (2700 mg) and 1
primidone (PRM) (625 mg)).
All patients received total intravenous anaesthe-
sia (TIVA) with propofol and remifentanil; three
patients received additional inhalation anaesthesia
with isoflurane. In all patients rocuronium or cisa-
tracurium was used for muscle relaxation, and
40 mg dexamethasone, 2 g ceftriaxone or 3 g ampi-
cillin/sulbactam and 1 or 2 g metamizole were
administered at the end of the operation. Mean
duration of the operations was 275 min (120—390,
S.D. 67.4). As the intra- and postoperative blood loss
could not be quantified precisely in the majority of
cases, we decided to exclude this variable. Post-
operative drug regimes varied remarkably: 17 out of
20 patients received oral dexamethasone starting
with 24 mg daily (3  8 mg) on POD 1 and a daily
dose reduction of 4—6 mg; 3 patients did not receive
steroids. In 12 cases the H2-antihistamine ranitidine
was given for postoperative ulcer prophylaxis, 3
patients had proton pump inhibitors (omeprazole,
esomeprazole) and 5 patients had no ulcer prophy-
laxis. Seven out of 20 patients received paracetamol
(acetaminophen) for postoperative analgesia; 13
patients received other oral analgetics (metami-
zole, ibuprofen).
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postoperative monitoring of the patients until dis-
charge from the ward (usually 10—14 days after
surgery) included the following procedures: drawing
of blood samples (white blood cell count, haemo-
globin, platelet count, Na, K, CRP, glucose, liver
enzymes) at least every other day, daily measure-
ment of body temperature, measurement of blood
pressure and pulse three times daily, urine analysis
at least once during the first few postoperative days,
and a neurological examination at least every other
day. If necessary, further diagnostic examinations
(computed tomography of the brain, ECG, etc.)
were performed.
Statistics
Established parameters of descriptive statistics
(mean, range, standard deviation) were calculated.
A Wilcoxon rank-sum test was used for pre- and
postoperative comparisons, and a Mann—Whitney
test for between group comparisons. A p-value
<0.05 was considered significant. All procedures
were performed with SPSS version 12.0.Results
In the entire group, mean decrease of LTG serum
levels from the preoperative baseline was 37% (mean
preoperative level 8.1 mg/l (3.4—16.2, S.D. 3.6),
lowest mean postoperative level 5.1 mg/l (1.4—
9.9, S.D. 2.6; p = 0.001). Sixteen out of 20 patients
(80%) showed a decrease in LTG serum levels from
baseline of more than 20% (21.9—69.1%, mean 46%)
(p < 0.001, Table 1, Fig. 1), 2 patients had increasedTable 1 Mean pre- and postoperative serum levels (range)
from preoperative baseline
Several subgroups with different postoperative medications are liste
antihistamines; PPI: proton pump inhibitors; S.D.: standard dev
p < 0.001.serum levels (+41.1%, +35.9%) and 2 patients showed
minor changes (7.7%, +15.3%). Decrease of LTG
serum levels did not differ significantly between
men and women, patients with or without paraceta-
mol, with or without isoflurane anaesthesia, with
different medication for ulcer prophylaxis or with
or without dexamethasone. Furthermore, the mag-
nitude of the decrease was influenced neither by age
nor by the preoperative serum level.
Six patients (four with LTG monotherapy, two
with LEV co-medication) suffered from one or more
seizures within the early postoperative period (POD
1 to POD 13); two additional patients presumably
had one seizure each, but documentation was insuf-
ficient. Five out of the six patients showed a reduc-
tion in LTG levels of between 22.2% and 66.3% (mean
48.4%) from the preoperative baseline, one patient
had a non-significant increase of 15.3%. There was,
however, no significant difference in decrease of
serum levels between the group of patients with
documented postoperative seizures (n = 6) and the
group of patients without postoperative seizures
(n = 14). In four patients with postoperative sei-
zures, serum levels from the day on which the
seizures occurred were documented in the medical
records. In three of these patients seizures corre-
lated with the nadir of the serum levels (pat. 9: POD
5, decrease of 52.7%; pat. 11: POD 4, decrease of
66.3%; pat. 14: POD 4, decrease of 22.2%; see Fig. 1,
red circles). The fourth patient (pat. 12, LTG mono-
therapy) had one seizure on POD 3; the serum level
on this day was 8.2 mg/l versus 9.9 mg/l preopera-
tively. This patient’s LTG level further decreased to
5.8 mg/l, which led to the administration of 30 mg
clobazam. The remaining two patients with post-
operative seizures had serum levels drawn 1 dayof LTG in 16 patients with a decrease of more than 20%
d. Abbreviations–—PCM: paracetamol (acetaminophen); H2: H2-
iation. *Difference significant from preoperative baseline at
482 F. Paul et al.prior to or not more than 1 day after the seizure.
Patient 2 (LTG monotherapy) had blood samples
drawn 2 days prior to and 1 day after the seizure;
at both timepoints, serum levels were reduced (pre-
operative: 7.4 mg/l, POD 1: 3.0 mg/l (59.5%), POD
4: 5.1 mg/l (31.1%)). Patient 19 (co-medication
with LEV) had a seizure on POD 1, the LTG serum
level on POD 2was 6.8 mg/l compared to a preopera-
tive value of 5.9 mg/l. In all six patients suffering
from postoperative seizures a dose augmentation of
LTG (between 50 mg and 200 mg daily, increase of
between 10% and 25% compared to the preoperative
dose) was performed and/or additional clobazam
medication was temporarily administered to prevent
further seizures. In none of these 6 patients were the
postoperative seizures related to fever, infections, or
laboratory abnormalities such as metabolic distur-
bances or electrolyte imbalance.
In the subgroup of eight patients with anticonvul-
sant co-medication, serum levels changed as follows:
the PRM (1 pat.) and VPA (1 pat.) levels remained
unchanged (pre-/postoperative 6.0 mg/l versus
5.2 mg/l and 102 mg/l versus 96 mg/l, respectively),
the patient with OXC co-medication showed a
decrease of 41.8%, 1 patient with CBZ co-medication
had a fair increase (pre-/postoperative 7.3 mg/l
versus 10.8 mg/l) and the second CBZ patient had
a decrease of 51.6%. LEV serum levels (3 pats.) were
not routinely examined as there was no valid assay
available at that time in our institution.Discussion
Our study revealed a pronounced decrease of
between 22% and 69% of LTG serum levels in 16
out of 20 patients (80%) compared to the preopera-
tive steady state. Amongst these 16 patients, 5 had
postoperative seizures between POD 1 and POD 13.
In 3 of these, seizures were associated with the LTG
serum level nadir. As the postoperative seizures in
these patients could not be explained by fever,
infections or laboratory abnormalities, it is very
likely that the reduction of LTG serum levels after
surgery played a crucial role. Reduction of AED
serum levels is a well-known seizure-provoking con-
dition.9 The factors contributing to the postopera-
tive decrease of serum levels are, however, elusive.
Besides the surgical procedure itself, possible influ-
encing factors include the anaesthetic drugs, the
perioperative medication (muscle relaxation, anti-
biotics) and the postoperative medication, which
included dexamethasone, H2-antihistamines (rani-
tidine) or proton pump inhibitors (omeprazole,
esomeprazole), and the analgetics paracetamol
(acetaminophen), metamizole and ibuprofen. Littleis known about drug interactions of these co-med-
ications with LTG or other AED.
Feil et al.8 examined perioperative serum levels
of LTG and OXC, and found relevant fluctuations in
patients who received isoflurane and barbiturates
as anaesthetics. However, none of our patients
received barbiturates, and only three had isoflur-
ane anaesthesia; these patients did not show a
more pronounced reduction in LTG levels than the
patientswithout isoflurane. Therefore, isoflurane is
unlikely to be the major cause of the decreased
serum levels.
Another influencing co-medication may be dexa-
methasone, which was administered in 17 patients.
Sabers et al. found a significant reduction of LTG
levels under oral contraceptives10,11 and speculated
that this might be due to the elimination of LTG
primarily by glucuronidation, as oral contraceptives
induce themetabolism of some other glucuronidated
drugs such as paracetamol and clofibric acid.12,13
Dexamethasone is a steroid as well, so similar effects
on thepharmacokinetics of LTGmaybeassumed. Two
of 3 patients who did not receive dexamethasone had
only minor fluctuations in their LTG levels (7.7%,
+15%), but the small number of patients does not
allow firm conclusions to be drawn regarding possible
interactions of LTG with dexamethasone.
Drug interactions of H2-antihistamines and pro-
ton pump inhibitors with LTG have not been thor-
oughly investigated. Although sample sizes were
limited, the lack of changes dependent on these
drugs in our study is in line with Ebert et al., who
found negligible effects of the H2-antihistamine
cimetidine on the pharmacokinetics of LTG in
healthy subjects after administration of a single
oral dose of 25 mg LTG.14
Paracetamol (acetaminophen), given in seven
cases for postoperative analgesia, can reduce LTG
serum levels.15 This may be a relevant co-factor in
some patients but cannot explain sufficiently the
decrease of postoperative LTG serum levels in the
entire cohort, as the magnitude of the decrease was
similar in patients with and without paracetamol
(Table 1).
The fact that our study could not show a firm
association between the decrease of the serum
levels and certain co-medications may be due to
the lack of standardised treatment regimes in the
early postoperative period, leading to small sample
sizes in the different subgroups. On the other hand,
this observation may equally point to the anaes-
thetics (TIVA, given to all patients in our cohort) as a
factor influencing postoperative serum level reduc-
tions. All types of anaesthesia may cause delayed
gastric emptying and alteration of bowel motility,16
which has also been separately shown for TIVA
Perioperative fluctuations of lamotrigine serum levels 483with propofol and remifentanil in humans.17 This
may lead to a delayed absorption of orally adminis-
tered medications and an alteration of their
bioavailability.16,17
The major limitation of our study is, thus, its
retrospective character and the relatively small
sample size, which hampers the assessment of the
impact of the perioperative procedures (surgery,
anaesthesia, postoperative medication) on the
serum levels of LTG. However, as our knowledge
of perioperative fluctuations in AED serum levels
is exiguous, this work alerts us to the relevance of
decreased AED serum levels as a factor contributing
to early postoperative seizures. Early postoperative
seizures of whatever cause may have a negative
psychological impact on patients, who signed con-
sent for epilepsy surgery with high expectations
regarding seizure freedom, mostly after a long his-
tory of medically intractable epilepsy. Furthermore,
early postoperative seizures may have negative
prognostic implications for later outcome.2—4 As
certain conditions related to surgery, such as anaes-
thesia, are unavoidable, all susceptible factors
which can contribute to postoperative seizures,
such as decrease of serum levels of AED, should
be eliminated as far as possible. Presumably, a post-
operative reduction of serum levels is not a phe-
nomenon specific to LTG: the serum levels of other
AED might also be influenced by perioperative pro-
cedures, anaesthetics and postoperative medica-
tion, a possibility which needs further evaluation.
The very small number of patients with anticonvul-
sants given as co-medication in our study (CBZ, PRM,
LEV, VPA, OXC) does not permit any conclusions to be
made regarding these AED. Interestingly, elevated
postoperative serum levels of CBZ were reported in
a previous retrospective study in about 50% of
patients undergoing epilepsy surgery, and interac-
tion with fentanyl was assumed.7 On the other hand,
9% had a reduction of postoperative CBZ levels in the
same study.
As an increasing number of patients will probably
be eligible for epilepsy surgery owing to improved
selection procedures and optimised surgical techni-
ques, prospective studies are urgently needed to
assess the factors influencing perioperative fluctua-
tions in AED serum levels and their impact on early
postoperative seizures. It would be desirable to
reach a consensus amongst experts in the field on
a standardized perioperative management of
patients undergoing epilepsy surgery regarding
anaesthesia, postoperative co-medication presum-
ably interacting with the AED, and dose titration of
the AED.
The results of our study lead us to make the
following recommendations regarding the perio-perative management of epilepsy patients with
LTG: (i) a preoperative dose augmentation of 10—
20% should be considered in order to avoid insuffi-
cient postoperative serum levels and to eliminate
one susceptible factor which contributes to post-
operative seizures; (ii) a subsequent reduction in
dosage to the preoperative steady-state dose could
be performed about 2 weeks later after discontinua-
tion of other potentially interacting drugs such as
steroids, drugs for ulcer prophylaxis and analgetics;
(iii) postoperative serum levels of LTG should be
monitored closely (at least every other day) during
the first 2 postoperative weeks; (iv) a serum level
reduction of more than 20% should initiate further
cautious dose augmentation and/or temporary add-
on medication with benzodiazepines; (v) postopera-
tive analgesia with paracetamol should be handled
with caution, as an interaction with LTG cannot be
ruled out. Therefore, metamizole or ibuprofen may
be preferable alternatives.Appendix A. Supplementary data
Supplementary data associated with this article
can be found, in the online version, at doi:10.1016/
j.seizure.2007.03.006.References
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